Kampa, M., and Castanas, E.: Membrane steroid receptor signaling in normal and neoplastic cells. Mol. Cell. Endocrinol. 2006, 246:76–82.
Löwenberg, M., Verhaar, A.P., van den Brink, G.R., and Hommes, D.W.: Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol. Med. 2007, 13:158–163.
Rhen, T., and Cidlowski, J.A.: Antiinflammatory action of glucocorticoids— new mechanisms for old drugs. N. Engl. J. Med. 2005, 353:1711–1723.
Barnes, P.,J.: Glucocorticosteroids: current and future directions. Br. J. Pharmacol. 2011, 163:29–43.
16-2 Cytotoxic drugs cause immunosuppression by killing dividing cells and have serious side-effects.
Aarbakke, J., Janka-Schaub, G., and Elion, G.B.: Thiopurine biology and pharmacology. Trends Pharmacol. Sci. 1997, 18:3–7.
Allison, A.C., and Eugui, E.M.: Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation 2005, 802 Suppl.: S181–S190.
O’Donovan, P., Perrett, C.M., Zhang, X., Montaner, B., Xu, Y.Z., Harwood, C.A., McGregor, J.M.,Walker, S.L., Hanaoka, F., and Karran, P.: Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005, 309:1871–1874.
Taylor, A.L., Watson, C.J., and Bradley, J.A.: Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit. Rev. Oncol. Hematol. 2005, 56:23–46.
Zhu, L.P., Cupps, T.R., Whalen, G., and Fauci, A.S.: Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells. J. Clin. Invest. 1987, 79:1082–1090.
16-3 Cyclosporin A, tacrolimus, rapamycin and JAK inhibitors are effective immunosuppressive agents that interfere with various T-cell signaling pathways.
Araki, K., Turner, A.P., Shaffer, V.O., Gangappa, S., Keller, S.A., Bachmann, M.F., Larsen, C.P., and Ahmed, R.: mTOR regulates memory CD8 T-cell differentiation. Nature 2009, 460:108–112.
Battaglia, M., Stabilini, A., and Roncarolo, M.G.: Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005, 105:4743–4748.
Bierer, B.E., Mattila, P.S., Standaert, R.F., Herzenberg, L.A., Burakoff, S.J., Crabtree, G., and Schreiber, S.L.: Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc. Natl Acad. Sci. USA 1990, 87:9231–9235.